Gilder Gagnon Howe & Co’s eHealth EHTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-105,205
Closed -$7.43M 397
2020
Q4
$7.43M Sell
105,205
-47,640
-31% -$3.62M 0.04% 198
2020
Q3
$12.1M Sell
152,845
-97,704
-39% -$7.92M 0.07% 160
2020
Q2
$24.6M Sell
250,549
-11,087
-4% -$1.29M 0.19% 110
2020
Q1
$36.8M Buy
261,636
+49,565
+23% +$5.68M 0.44% 73
2019
Q4
$20.4M Sell
212,071
-222,213
-51% -$17.2M 0.21% 100
2019
Q3
$29M Sell
434,284
-115,416
-21% -$10.4M 0.33% 83
2019
Q2
$47.3M Sell
549,700
-3,598
-0.7% -$242K 0.48% 67
2019
Q1
$34.5M Buy
553,298
+72,093
+15% +$3.97M 0.37% 73
2018
Q4
$18.5M Buy
481,205
+19,944
+4% +$671K 0.26% 79
2018
Q3
$13M Buy
461,261
+366,954
+389% +$9.74M 0.13% 124
2018
Q2
$2.08M Buy
+94,307
New +$1.82M 0.02% 202
2015
Q1
Sell
-1,105,681
Closed -$27.6M 271
2014
Q4
$27.6M Buy
1,105,681
+118,365
+12% +$2.88M 0.41% 60
2014
Q3
$23.8M Buy
987,316
+284,437
+40% +$7.76M 0.35% 65
2014
Q2
$26.7M Sell
702,879
-176,843
-20% -$7M 0.35% 65
2014
Q1
$44.7M Buy
879,722
+846,014
+2,510% +$44.1M 0.61% 54
2013
Q4
$1.57M Buy
+33,708
New +$1.41M 0.02% 198

Other funds holding EHTH

Gilder Gagnon Howe & Co's EHTH Position: Q1 2021 in Review

Gilder Gagnon Howe & Co sold out of eHealth (EHTH) in Q1 2021, closing a stake of 105,205 shares — an estimated $7.43M sold.

Gilder Gagnon Howe & Co first reported a position in EHTH in Q4 2013 and held it in 16 quarters. The position peaked at $47.3M in Q2 2019. 197 funds tracked by Wall St. Rank hold EHTH as of Q1 2021.

  • Gilder Gagnon Howe & Co reported no remaining eHealth position as of Q1 2021 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 105,205 eHealth shares in Q1 2021, an estimated $7.43M.
  • Gilder Gagnon Howe & Co first reported a position in eHealth in Q4 2013 and held it in 16 quarters.
  • Gilder Gagnon Howe & Co's eHealth position peaked at $47.3M in Q2 2019.
  • 197 funds tracked by Wall St. Rank held eHealth as of Q1 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2021, filed 17 May 2021.